You just read:

Protalix BioTherapeutics Presents Key Clinical Data of Pegunigalsidase Alfa for the Treatment of Fabry Disease at the 16th Annual WORLDSymposium™ 2020

News provided by

Protalix BioTherapeutics, Inc.

Feb 10, 2020, 16:05 ET